It has been suggested that aquaporin 9 (AQP9), a member of the aquaporin superfamily, is responsible for AsIII uptake into leukemia cells and has become a promising target in the development of treatment strategies against APL [19,51]. This evidence concerns the gene AQP9 and acute promyelocytic leukemia.